S 1607 Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Improving National Safety, Public health, Ethics, and Clinical Trials Act
To establish an Inspector General of the National Institutes of Health, an Inspector General of the Centers for Disease Control and Prevention, and an Inspector General for the Food and Drug Administration.
Summary
- Establishes separate Inspector General positions for the National Institutes of Health, the Centers for Disease Control and Prevention, and the Food and Drug Administration.
- Requires the President to appoint individuals to these three Inspector General positions within 1 year of enactment.
- Requires implementation using existing appropriations to the Office of the Inspector General of the Department of Health and Human Services, with no new funds authorized.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
-
Sen. Schmitt, Eric (R-MO)
Actions (2)
- May 6, 2025 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. · senate
- May 6, 2025 Introduced in Senate
Full text
IN THE SENATE OF THE UNITED STATES
May 6, 2025
Mr. Schmitt introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
A BILL
To establish an Inspector General of the National Institutes of Health, an Inspector General of the Centers for Disease Control and Prevention, and an Inspector General for the Food and Drug Administration.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Improving National Safety, Public health, Ethics, and Clinical Trials Act” or the “INSPECT Act”.
SEC. 2. ESTABLISHMENT OF INSPECTORS GENERAL OF THE NATIONAL INSTITUTES OF HEALTH, THE CENTERS FOR DISEASE CONTROL AND PREVENTION, AND THE FOOD AND DRUG ADMINISTRATION.
(a) Definitions.—Section 401 of title 5, United States Code, is amended—
(1) in paragraph (1), by striking “or the National Reconnaissance Office,” and inserting “the National Reconnaissance Office, the National Institutes of Health, the Centers for Disease Control and Prevention, or the Food and Drug Administration,”; and
(2) in paragraph (3), by striking “or the Director of the National Reconnaissance Office;” and inserting “the Director of the National Reconnaissance Office; the Director of the National Institutes of Health; the Director for the Centers for Disease Control and Prevention; or the Commissioner of Food and Drugs,”.
(b) Appointment of Inspectors General.—Not later than 1 year after the date of enactment of this Act, the President shall, in accordance with section 403(a) of title 5, United States Code—
(1) appoint an individual to serve as the Inspector General of the National Institutes of Health;
(2) appoint an individual to serve as the Inspector General of the Centers for Disease Control and Prevention; and
(3) appoint an individual to serve as the Inspector General of the Food and Drug Administration.
SEC. 3. COMPLIANCE WITH CUTGO.
This Act and the amendments made by this Act shall be carried out using amounts otherwise appropriated to the Office of the Inspector General of the Department of Health and Human Services, and no additional amounts are authorized to be appropriated to carry out this Act or the amendments made by this Act. <all>
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Comments